Page last updated: 2024-08-24

gemcitabine and Adenoviridae Infections

gemcitabine has been researched along with Adenoviridae Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Anttila, M; Arias, V; Basnet, S; Cervera-Carrascon, V; Clubb, JHA; Grönberg-Vähä-Koskela, S; Havunen, R; Haybout, L; Heiniö, C; Hemminki, A; Jirovec, E; Kudling, TV; Pakola, S; Quixabeira, DCA; Santos, JM	1

Other Studies

1 other study(ies) available for gemcitabine and Adenoviridae Infections

Article	Year
An oncolytic adenovirus coding for a variant interleukin 2 cytokine improves response to chemotherapy through enhancement of effector lymphocyte cytotoxicity, fibroblast compartment modulation and mitotic slippage. Frontiers in immunology, 2023, Volume: 14 Topics: Adenoviridae; Adenoviridae Infections; Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cytokines; Fibroblasts; Gemcitabine; Interleukin-2; Lymphocytes; Mice; Pancreatic Neoplasms; Tumor Microenvironment	2023

Article

Year

An oncolytic adenovirus coding for a variant interleukin 2 cytokine improves response to chemotherapy through enhancement of effector lymphocyte cytotoxicity, fibroblast compartment modulation and mitotic slippage.

Frontiers in immunology, 2023, Volume: 14

Topics: Adenoviridae; Adenoviridae Infections; Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cytokines; Fibroblasts; Gemcitabine; Interleukin-2; Lymphocytes; Mice; Pancreatic Neoplasms; Tumor Microenvironment

2023